1 / 16

An example of low-cost, simple interventions in drug demand reduction

Explore low-cost interventions for drug demand reduction and treatment by leveraging biological markers and targeted pharmacological agents. Learn about prevention strategies and evidence-based treatments.

rosenbergr
Download Presentation

An example of low-cost, simple interventions in drug demand reduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. An example of low-cost, simple interventions in drug demand reduction Gilberto Gerra Drug Prevention and Health Branch Division for Operations

  2. The winning strategy

  3. Do youbelieveinpreventionofdruguseand treatment ofdrugdependence? Complex, confused, unrealistic, fantasy-based, ineffective…

  4. Prevention of cardiovascular diseases – Poker of Aces • No smoking • No salt • No cholesterol • Physical exercise

  5. Do we have a poker of aces for drug demand reduction?

  6. Prevention of drug use

  7. Prevention of drug use

  8. Prevention of drug use

  9. Prevention of drug use

  10. Treatment of drug dependence

  11. Treatment of drug dependence

  12. Treatment of drug dependence

  13. Treatment of drug dependence

  14. ‘One-stop-shop’

  15. Addict Biol. 2003 Jun;8(2):123-39. Biological markers of cocaine addiction: implications for medications development. Elkashef and Vocci, 2003 poor understanding of the underlying biology both in the premorbid condition and following the disease state of chronic cocaine use population heterogeneity specific biological changes/markers that could be used to characterize subgroups among chronic cocaine users targeting specific pharmacological agents to subgroups of patients

  16. Seroronin agonists (fluoxetine, citalopram) Serotonin/noradrenaline agonists (venlafaxine-duloxetine) Dopamine agonists/antagonists (modafinil, methylphenidate) NMDA antagonists (memantine, dizocilpine…) Disulfiram GABA-b agonists (baclofen) Kappa-receptor antagonists (buprenorphine + naltrexone) Vaccine

More Related